Information Journal Paper
APA:
Copy. (2020). B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 43(-), 0-0. SID. https://sid.ir/paper/1094563/en
Vancouver:
Copy. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran. MULTIPLE SCLEROSIS AND RELATED DISORDERS[Internet]. 2020;43(-):0-0. Available from: https://sid.ir/paper/1094563/en
IEEE:
Copy, “B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran,” MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol. 43, no. -, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/1094563/en